DSS in cooperation with LUDC invites you to seminar: Early Clnical Diabetes Studies.
This seminar will focus on issues needed to consider when taking a pre-clinical project into early clinical development. The speakers have a deep knowledge of drug development strategy and execution gained from several years in research, pre-clinical and clinical development in academia, biotech and big pharma.
Date: October
Time: 09.30-13.00
Venue: Lecture Hall, Clinical Research Centre, Jan Waldenströms gata 35, Malmö.
Cost: Free of Charge
PROGRAMME
09.30 Registration
10:00-11:00 Business Development, Andreas Norlin
11:00-12:00 Early Clinical Studies, Cecilia Karlsson
12:00-12:15 Project Support and Counselling for Clinical Studies, Ulf Malmqvist
12:15-13:00 Lunch (on the CRC balcony)
Andreas Norlin, founder and Senior Advisor at Xkout Bioscience will discuss business development; incl. unmet patient needs, positioning and IP-strategy.
Cecilia Karlsson, Senior Medical Lead at AstraZeneca will talk about the process of clinical studies, strategic considerations, as well as innovative approaches that can speed up the process.
Ulf Malmqvist, CEO of Clinical Studies Sweden – Forum South, a regional support organization for medical research funded by the Research Council and Region Skåne, will present support offered to researchers and companies in the planning and execution phase.
After lunch, there is also an opportunity to book one-to-one meetings with Cecilia Karlsson and Andreas Norlin for those of you that require an in-depth discussion or advice in relation to the needs in your specific projects.
Registration
Please register no later than October 20th by sending an email to Thomas.gunnarsson@med.lu.se. At the same time specify if you would like to book a one hour meeting with Cecilia or Andreas in the afternoon.
Welcome!
